Company / Net Income
SOLENO THERAPEUTICS INC Net Income History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
$20.9M
FY2025
5-year range
-$175.8M / $20.9M
FY2021-FY2025
Trend
+111.9%
vs FY2024
Sector context
#53 of 214
Health Care
What the data says
SOLENO THERAPEUTICS INC's net income of $21M is higher than 75% of companies in the Health Care sector (FY2025). Net Income returned to growth in FY2025 after 2 years of decline, reaching $21M.
Based on SEC 10-K filings.
$21M in FY2025. Top quartile in the Health Care sector.
Improved from -$39M to $21M over the past 2 years.
Health Care sector context is included.
Net Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 25% in Health CareTop 25% of 214This company $20.9M Sector average $442.7M
▼
-95.3% below sector average
Key checks
Key Insights
- In FY2025, net income increased 111.9% year-over-year.
- Ranks #53 out of 214 companies in the Health Care sector.
- Lowest net income in the period was in FY2024.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $20.9M | +111.9% |
| FY2024 | -$175.8M | -351.0% |
| FY2023 | -$39.0M | -62.0% |
| FY2022 | -$24.1M | +22.1% |
| FY2021 | -$30.9M | -25.5% |
| FY2020 | -$24.6M | +19.9% |
| FY2019 | -$30.8M | -130.8% |
| FY2018 | -$13.3M | +13.3% |
| FY2017 | -$15.4M | -27.5% |
| FY2016 | -$12.1M | +24.2% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026